Literature DB >> 26453333

Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation.

Feng Wan1, Emmanuel Letavernier2, Claude Jourdan Le Saux3, Amal Houssaini1, Shariq Abid1, Gabor Czibik1, Daigo Sawaki1, Elisabeth Marcos1, Jean-Luc Dubois-Rande4, Laurent Baud2, Serge Adnot5, Geneviève Derumeaux5, Barnabas Gellen6.   

Abstract

The activation of the calpain system is involved in the repair process following myocardial infarction (MI). However, the impact of the inhibition of calpain by calpastatin, its natural inhibitor, on scar healing and left ventricular (LV) remodeling is elusive. Male mice ubiquitously overexpressing calpastatin (TG) and wild-type (WT) controls were subjected to an anterior coronary artery ligation. Mortality at 6 wk was higher in TG mice (24% in WT vs. 44% in TG, P < 0.05) driven by a significantly higher incidence of cardiac rupture during the first week post-MI, despite comparable infarct size and LV dysfunction and dilatation. Calpain activation post-MI was blunted in TG myocardium. In TG mice, inflammatory cell infiltration and activation were reduced in the infarct zone (IZ), particularly affecting M2 macrophages and CD4(+) T cells, which are crucial for scar healing. To elucidate the role of calpastatin overexpression in macrophages, we stimulated peritoneal macrophages obtained from TG and WT mice in vitro with IL-4, yielding an abrogated M2 polarization in TG but not in WT cells. Lymphopenic Rag1(-/-) mice receiving TG splenocytes before MI demonstrated decreased T-cell recruitment and M2 macrophage activation in the IZ day 5 after MI compared with those receiving WT splenocytes. Calpastatin overexpression prevented the activation of the calpain system after MI. It also impaired scar healing, promoted LV rupture, and increased mortality. Defective scar formation was associated with blunted CD4(+) T-cell and M2-macrophage recruitment.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  calpain; calpastatin; cardiac rupture; inflammation; lymphocytes; macrophages; myocardial infarction; scar healing

Mesh:

Substances:

Year:  2015        PMID: 26453333     DOI: 10.1152/ajpheart.00594.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

Review 1.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

2.  Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction.

Authors:  Anis Hanna; Arti V Shinde; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-04       Impact factor: 4.733

Review 3.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

4.  Over-expression of calpastatin attenuates myocardial injury following myocardial infarction by inhibiting endoplasmic reticulum stress.

Authors:  Shuai Li; Jian Ma; Jing-Bo Li; James C Lacefield; Douglas L Jones; Tian-Qing Peng; Meng Wei
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 5.  Effects of functionally diverse calpain system on immune cells.

Authors:  Yueqi Chen; Zhaoliang Su; Fang Liu
Journal:  Immunol Res       Date:  2021-01-23       Impact factor: 2.829

6.  Specific calpain inhibition protects kidney against inflammaging.

Authors:  Guillaume Hanouna; Laurent Mesnard; Sophie Vandermeersch; Joëlle Perez; Sandrine Placier; Jean-Philippe Haymann; Fabien Campagne; Julien Moroch; Aurélien Bataille; Laurent Baud; Emmanuel Letavernier
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

7.  Guidelines for experimental models of myocardial ischemia and infarction.

Authors:  Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

Review 8.  Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond.

Authors:  Jonasz Jeremiasz Weber; Priscila Pereira Sena; Elisabeth Singer; Huu Phuc Nguyen
Journal:  Biomed Res Int       Date:  2019-02-14       Impact factor: 3.411

9.  Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.

Authors:  Minghui Li; Yangang Su; Yong Yu; Ying Yu; Xinggang Wang; Yunzeng Zou; Junbo Ge; Ruizhen Chen
Journal:  Int J Cardiol       Date:  2016-07-09       Impact factor: 4.164

10.  Spatio-temporal regulation of calpain activity after experimental myocardial infarction in vivo.

Authors:  Kun Zhang; Melissa M Cremers; Stephan Wiedemann; David M Poitz; Christian Pfluecke; Frank R Heinzel; Burkert Pieske; Volker Adams; Antje Schauer; Robert Winzer; Ruth H Strasser; Axel Linke; Silvio Quick; Felix M Heidrich
Journal:  Biochem Biophys Rep       Date:  2021-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.